A 2018 review of sixteen research of cannabis-primarily based medicines for neuropathic agony, nearly all of which examined a cannabinoid planning referred to as nabiximols (brand identify Sativex; a mouth spray containing each THC and CBD that is certainly authorized in certain international locations but not in The us), identified lower- to reaso